CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Depuy Synthes Advanced Retrograde femoral naildevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05668117
NCT05668117N/ACompleted

RFN-Advanced Retrograde Femoral Nailing System (RFNA) - Early Usage Case-Series Utilizing the Retrograde Femoral Nail-Advanced for Fixation and Stabilization of the Distal Femur and Femoral Shaft

University of Alabama at Birmingham·observational·Posted Dec 29, 2022·Updated May 1, 2023

In Brief

An observational study evaluating Depuy Synthes Advanced Retrograde femoral nail for Femur Fracture. Completed, enrolled 53 participants across 1 site.

Detailed Summary

This study is a retrospective chart review of the safety and performance Standard of Care data on individuals that have previously been implanted with the femur nail of the RFNA System for the internal fixation of the femur. Demographics, medical history, primary diagnosis, mechanism of injury, type of injury, clinical and radiographic evaluation of bone consolidation, and device-related adverse events were collected. Descriptive statistics were applied to the data collected.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFemur Fracture
CountriesUnited States
CollaboratorsDePuy Synthes

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 29, 2022
Enrollment StartFeb 1, 2021
Primary CompletionJul 31, 2022
Study CompletionApr 27, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.5 years ago

Interventions

Depuy Synthes Advanced Retrograde femoral naildevice

The Advanced Retrograde Femoral Nailing System (RFNA) is designed to improve fixation and stabilization of distal femur and femoral shaft fractures by reducing toggle and loss of reduction.